Abstract
Encephalopathy of prematurity (EOP) is a histologically defined condition common in preterm infants characterized by cerebral white matter injury/periventricular leukomalacia with a variety of associated neuronal/axonal deficits. The fetal/maternal and neonatal conditions leading to EOP are those typically associated with cerebral ischemia and systemic infection/inflammation. Recognizing the neurologic correlates of EOP for infants in the NICU is challenging because the clinical manifestations are not particularly distinctive. As a result, the diagnosis of EOP relies heavily on EEG and neuroimaging studies, mainly head ultrasound and EEG. Infants with EOP have a high incidence of chronic neurodevelopmental impairment in a variety of areas—motor coordination, visual function, cognitive function, language ability, socialization, and behavior. These impairments can be predicted, to some degree, with neuroimaging findings and their known neuropathologic correlates. Clinical management of preterm infants during the neonatal period may influence outcome, and relevant elements include administration of steroids prior to delivery as well as management of oxygen levels, carbon dioxide levels, blood pressure, glucose levels, seizures, and patent ductus arteriosus. Neuroprotective strategies that might mitigate the effects of EOP are currently under evaluation. Among these are erythropoietins, epidermal growth factor, insulin-like growth factor, and stem cell administration. Finally, the environment of the NICU itself is important for optimizing neurodevelopmental outcomes. Factors such as auditory exposure, visual exposure, and human contact should be taken into account in NICU management.
Keywords
Encephalopathy of prematurity, Preterm infant, Electroencephalography, Ultrasound, Magnetic resonance imaging, Neurologic outcome (preterm)
This chapter addresses the clinical aspects of the encephalopathy of prematurity, a term coined to characterize the multifaceted, nonhemorrhagic white and gray matter lesions in the premature brain that reflect a combination of destructive and dysmaturational effects (see Chapter 14 ). The central pathology is cerebral white matter injury (WMI)/periventricular leukomalacia (PVL), with a variety of associated neuronal/axonal deficits. The latter affect principally cerebral cortex and deep gray matter structures, especially thalamus (see Chapter 14 ). Other lesions also often present in preterm infants include germinal matrix-intraventricular hemorrhage (IVH) (see Chapter 24 ) and cerebellar disturbances (see Chapters 4 and 23 ), which are discussed elsewhere in this book. The pathophysiology of the encephalopathy of prematurity is multifactorial, but principally involves molecular events initiated by hypoxia-ischemia and systemic inflammation (see Chapter 15 ). The prevailing underlying theme is initial primary injury leading to secondary dysmaturation (see Chapter 14 ). Because the encephalopathy is diverse regionally, the spectrum of neurodevelopmental impairments is broad and includes, often in combination, a variety of cognitive, behavioral, socialization, attentional, and motor deficits (see later).
Clinical Settings
The rate of preterm birth (<37 weeks’ gestation) remains slightly higher than 10% worldwide, with rates varying from 5% to 18% across 184 countries studied ( http://www.who.int.easyaccess2.lib.cuhk.edu.hk/mediacentre/factsheets/fs363/en/ ). This relatively high frequency translates into more than 15 million preterm births worldwide in 2010. In the United States, the preterm birthrate has shown a slow and steady decline over the past decade, reaching 9.6% for the period 2012 to 2014 (March of Dimes Premature Birth Report Card; http://www.marchofdimes.org/mission/prematurity-reportcard.aspx ), corresponding to nearly 400,000 newborns born preterm per year. Preterm birth is a leading cause of long-term neurological disabilities in children and has been estimated to have cost the US health care system more than $26 billion in 2005. A disproportionate fraction of these costs originates from very preterm infants (VPT, <32 weeks’ gestation), who account for more than 2/3 of the costs associated with preterm birth despite representing just 20% of the preterm population. A particularly vulnerable subgroup is the very low birthweight (VLBW) infant (<1500 g at birth). In 2014, this group comprised 1.4% of total births (approximately 4,000,000), corresponding to approximately 55,000 infants per year in the United States. In addition, the survival of preterm infants has improved over the past decades, particularly for those born extremely preterm (<28 weeks’ gestation). For example, survival of infants born at 22 to 28 weeks’ gestation increased from 70% in 1993 to 79% in 2012. While these advances are encouraging, the morbidity associated with preterm birth—including impairments in development, learning, behavior, and social interaction—remains high. In a study examining data from the year 2012, survival without morbidity ranged from 9% for infants born at 24 weeks’ gestation to 59% for those born at 28 weeks’ gestation. Finally, the incidence of late preterm births (34 to 36 weeks’ gestation) has remained steady at approximately 6.8%, corresponding to 270,000 births per year in the United States. While late preterm infants tend to be less severely affected than infants from other preterm groups, neuropathological studies show that the spectrum of brain injury is similar to that found in early preterm infants, although the injury is generally less severe.
The principal clinical settings for the encephalopathy of prematurity include especially those for PVL, the unifying pathology ( Table 16.1 ). As discussed in Chapter 15 , the major pathogenetic themes are cerebral ischemia and systemic infection/inflammation (maternal infection/fetal systemic inflammation or neonatal infection/systemic inflammation). The propensity to ischemia relates especially to the high frequency of a pressure-passive cerebral circulation, particularly in the sick, ventilated infant, a variety of cardiorespiratory events leading to periods of decreased blood pressure, and respiratory complications associated with hypocarbia or hypoxemia (see Chapter 15 ). The relation to maternal intrauterine or neonatal infection and fetal or neonatal systemic inflammation indicates importance for clinical settings indicative of placental inflammation, documented early neonatal infection, and noninfectious disorders with severe systemic inflammation, especially necrotizing enterocolitis (see Chapter 15 ). Thus in view of the central importance of PVL, the encephalopathy of prematurity involves an interplay between two major initiating insults, hypoxia-ischemia and systemic infection/inflammation . Experimental studies provide strong evidence that these two insults can potentiate one another. Antenatal factors associated with adverse outcome for preterm infants include maternal diabetes, inadequate prenatal care, malnutrition, and maternal infection. Often in the latter studies, the distinction between antenatal factors that promote premature birth and those that lead directly or indirectly to cerebral injury is very difficult. Thus, overall, perinatal factors associated with increased risk of PVL include: (1) fetal metabolic acidosis; (2) systemic fetal inflammation; (3) respiratory insufficiency secondary to severe respiratory distress syndrome or recurrent apneic spells; (4) cardiac insufficiency secondary to severe respiratory disease, recurrent apneic spells, large patent ductus arteriosus, severe congenital cardiac disease, or vascular collapse (e.g., in association with sepsis); and/or (5) conditions that lead to elevated concentrations of inflammation-related proteins in the circulation, such as necrotizing enterocolitis (see Table 16.1 ; see later).
Primarily Hypoxia-Ischemia a |
|
Primarily Systemic Inflammation a |
|
a Hypoxia-ischemia and inflammation can be additive or potentiating, and the former is associated with a brisk inflammatory response.
NeurologicAL Syndrome
The acute neurological correlates of PVL, those that are present while the infant is in the neonatal intensive care unit (NICU), have been difficult to establish. This difficulty relates principally to the problems of carrying out a careful neurological examination in the sick, labile, premature infant and the frequent association of other neurological manifestations related to complicating hemorrhagic and neuronal injury. The ability to identify the focal component of this lesion in the neonatal period by ultrasonography has facilitated identification of some neonatal neurological correlates. In previous years, when large cystic PVL lesions were seen commonly in premature infants, we saw a substantial number of infants with weakness of lower limbs in the first weeks of life associated with focal periventricular white matter injury documented by ultrasound scan ( Table 16.2 ). In general, the weakness in the neonatal period is not marked, even in the presence of relatively large lesions. However, in recent years with the marked predominance of noncystic PVL, such specific motor deficits have been very unusual to identify. The frequent affection of optic radiations is consistent with electrophysiological studies that indicate a high incidence of disturbance of visual-evoked potentials, but impairments in visual perception and visual fields are not typically detectable until later in life (see Table 16.2 ).
TOPOGRAPHY OF THE MAJOR INJURY | NEONATAL PERIOD | LONG-TERM SEQUELAE |
---|---|---|
Periventricular white matter, including descending motor fibers, optic radiations, and association fibers; and associated deficits of cerebral cortex, basal ganglia, thalamus, and cerebellum | Probable lower limb weakness | Spastic diplegia Motor deficits (without spastic diplegia) Cognitive deficits Visual deficits Behavioral/attentional/socialization deficits |
Recognition of a distinct neonatal neurological syndrome associated with PVL and other anatomical features of the encephalopathy of prematurity also has been very difficult because of the rapidly changing normal neurological characteristics of the premature infant (see Chapter 9 ). For example, the normal infant of 28 weeks’ gestation requires stimulation for arousal from sleep. At 32 weeks’ gestation, spontaneous arousal occurs, but vigorous crying during wakefulness is unusual. Only at 40 weeks’ gestation should the observer expect to see discrete periods of attention to visual and auditory stimuli. Similarly, periodic breathing in a full-term newborn is much more likely to be an abnormal finding than in a premature infant at 32 weeks’ gestation. Further, absent pupillary reaction to light is usual at 28 weeks but is unusual at 32 to 34 weeks. However, full extraocular movements with oculocephalic (doll’s eyes) maneuver are present in the youngest normal infants (i.e., 28 weeks’ gestation or even younger). In addition, hypotonia in the upper extremities is usual at 28 or 32 weeks’ gestation but is abnormal at term. Finally, spontaneous movements also exhibit a progression from lower to upper extremities from 28 weeks’ gestation to term, so that weakness of upper extremities must be defined with caution in the premature infant.
The issue of neonatal seizures in the context of the sick preterm infant is critical to address ( Table 16.3 ). While neonatal seizures are characteristic of moderate to severe hypoxic-ischemic encephalopathy in the term infant (see Chapter 18 ), recent electrophysiological studies show that they also are common in VPT infants. However, only the minority of electrical seizures have an obvious clinical correlate in preterm (as well as term) infants (see Chapter 12 ). A recent study of 95 VPT infants evaluated by amplitude-integrated encephalography (aEEG) from the first day of life showed that fully 48% exhibited seizures in the first 72 hours of life. The presence of seizures on the second postnatal day was associated with white matter injury (detected by magnetic resonance imaging [MRI] at term equivalent age) (relative risk, 3.0 [1.3 to 6.6]). Only 7% of the infants with electrographic seizures had clinically detected seizures. Importantly, seizures were associated with poorer early language development. The data suggest that the clinical assessment of the very preterm infant should include diligent attempts at recognition of subtle seizures and liberal use of aEEG (see section on diagnosis ). The findings also have implications regarding the apparent perinatal timing of insults leading to PVL, as they suggest that injury sufficient to cause seizures occurs within the first days after birth (see later).
Amplitude-integrated EEG (aEEG) detected electrographic seizures in 48% of sick very preterm infants in the first 72 hours of life. |
Only 7% of the infants with electrographic seizures had clinically detected seizures. |
Seizures on postnatal day 2 were associated with cerebral white matter injury detected by magnetic resonance imaging at term equivalent age. |
Seizures were associated with poorer language development. |
Diagnosis
Unlike the term infant with hypoxic-ischemic encephalopathy, the value of the neurological examination and metabolic biomarkers in diagnosis of the encephalopathy of prematurity is limited. EEG has not been used extensively, although the potential value of conventional EEG and aEEG deserves exploration (see earlier and next section). Neuroimaging is of major diagnostic importance, and cranial ultrasonography and MRI are the key imaging methodologies.
Electroencephalogram
Because the encephalopathy of prematurity includes cerebral cortical and thalamic abnormalities (see Chapter 14 ), it is reasonable to expect that conventional or aEEG would provide important diagnostic information ( Table 16.4 ). Concerning conventional EEG, serial EEG studies have been shown of value in identifying preterm infants with PVL and presumed neuronal disease. Thus, in one important study, EEG findings referred to as acute-stage abnormalities ( decreased continuity, lower background amplitude, or both ) were observed mainly on days 1 to 4 of life in infants with subsequent ultrasonographically identified PVL. Later, chronic-stage abnormalities ( deformed slow activity and abnormal sharp waves ) were observed, mainly on days 5 to 14 and resolving within 1 to 2 months. Chronic-stage EEG abnormalities were more severe and persisted longer in patients with extensive cystic PVL compared with patients with milder PVL, suggesting that EEG findings correlate with PVL severity. Another EEG abnormality, positive rolandic sharp waves, has been identified as a specific, though not particularly sensitive, marker for overt PVL. The presence of additional abnormalities—occipital sharp waves (negative polarity) and frontal sharp waves (positive polarity)—increases sensitivity for cystic PVL. These EEG findings also are of prognostic value, as the presence of positive rolandic sharp waves has been associated with adverse motor outcome. Although brain injury such as grade III/IV IVH or cystic PVL detected by cranial ultrasound or MRI during the neonatal period is the most significant marker for predicting adverse outcomes (see later), EEG provides prognostic value independent of neuroimaging findings and clinical risk factors. In addition to abnormalities of EEG background, approximately 30% of patients with PVL presented with seizures and 65% with episodes of apnea.
“Acute-stage abnormalities”—decreased continuity, lower background amplitude, or both—observed on days 1–4 of life (and rarely thereafter) with subsequently proven PVL (ultrasonography) |
Abnormal sharp waves of value are positive rolandic or vertex (central), positive frontal, and negative occipital |
Positive rolandic sharp waves (>0.1/minute) present in 65%–90% of cases of severe PVL and 25% of mild or moderate PVL |
Frontal positive or occipital negative sharp waves or both present in 100% of cases of severe PVL and in 60%–90% of mild or moderate PVL |
Abnormal sharp waves accompany echodense lesions and precede the development of echolucent, presumed cystic change by ultrasonography |
Peak period of occurrence of sharp waves 5–14 days |
The findings described earlier regarding early detection of seizures by aEEG are relevant here (see Neurological Syndrome). Notably, the onset of aEEG seizures in the first days of life is consistent with the conventional EEG findings just described, suggesting that the timing of the insult(s) leading to the encephalopathy of prematurity involves early perinatal and neonatal events, at least initially.
Neuroimaging
Neuroimaging of Cerebral White Matter in the Encephalopathy of Prematurity
Relevant Neuropathology.
The hallmark of the encephalopathy of prematurity is cerebral white matter injury or PVL (see Chapter 14 ). To understand the value and the challenges of neuroimaging of the encephalopathy in the neonatal period, we should review briefly the neuropathology of PVL and related cerebral white matter injury. PVL consists of two distinct components: focal necrosis , with loss of all cellular elements, dorsal and lateral to the lateral ventricles, and a more cell-specific diffuse injury involving pre-oligodendrocytes (pre-OLs) in cerebral white matter and marked by astrogliosis and microgliosis. A spectrum of severity is recognized and in living infants is based on neuroimaging (principally MRI). Thus PVL can be categorized into three subtypes ( Table 16.5 ). The most severe form involves focal necroses that are macroscopic in size, that is, relatively large, more than several millimeters, and evolve to tissue dissolution and cystic change over a period of weeks. This focal necrotic/cystic form is often simply termed cystic PVL ( Fig. 16.1 ) and is readily detected by cranial ultrasonography or MRI (see later). Cystic PVL is now uncommon and has an overall incidence in living VLBW infants of 5% or less. In the largest neuropathological series of preterm infants ( n = 41), approximately 40% exhibited PVL with focal necroses, but macroscopic necroses were observed in only 18% of these PVL cases (only 7% of the total of autopsied preterm infants). A moderate form of PVL involves focal necrotic lesions that are 1 to 2 mm in size and, on tissue dissolution, evolve not to cysts but rather to focal glial scars, sometimes visible as punctate areas of increased signal intensity on T 1 -weighted MRI ( Fig. 16.2 ). This form, often termed noncystic PVL , occurs in approximately 25% of living infants. Finally, the least severe form of PVL involves a focal necrotic component less than 1 mm in size, that is, microscopic and so small as to be invisible to neuroimaging. This mild form, like all forms of PVL, exhibits the diffuse gliosis described in Chapter 14 . The degree of the diffuse abnormality generally correlates with the severity of PVL (see Table 16.5 ). The MRI correlate of the diffuse gliosis likely is the diffuse signal change described later. The mild form of PVL is likely present in a substantial minority of premature infants (see later). In the neuropathological series just noted, fully 82% of PVL cases (34% of the total series of autopsied premature infants) had focal necrotic lesions that were less than 1 mm and therefore likely below the detection of conventional clinical MRI scanners. Such cases would be classified (mistakenly) as nonnecrotic by MRI. All three subtypes of PVL include the diffuse component, characterized by astrogliosis/microgliosis, and, after the initial pre-OL cell death, an excess of oligodendroglial progenitors. These oligodendroglial progenitors, however, fail to differentiate into myelin-producing cells (see Chapters 14 and 15 ). The severity of the diffuse component appears to parallel the severity of the PVL.
FORM OF PVL | FOCAL PERIVENTRICULAR INJURY | DEGREE OF DIFFUSE WHITE MATTER INJURY a | IMAGING CORRELATE a | APPROXIMATE INCIDENCE (%) |
---|---|---|---|---|
Severe (“cystic”) | Large areas of macroscopic necrosis, evolving to cysts | Severe | Periventricular cysts | 5 |
Moderate (“noncystic”) | Smaller areas of macroscopic necrosis, evolving to gliotic scarring | Intermediate | Periventricular signal abnormality on CUS and punctate white matter lesions on MRI | 25 |
Mild | Microscopic areas of necrosis | Mild | No periventricular signal abnormality | ? 25–35 |
a The diffuse component of white matter injury is manifest on MRI as diffuse signal abnormality on T 2 -weighted imaging or as diffuse abnormalities on diffusion imaging.
A form of cerebral white matter injury with no necroses and only the diffuse white matter gliosis must be considered . It is noteworthy that in the total group of 41 autopsied premature infants by Pierson et al., approximately 40% had only diffuse gliosis, with no focal necroses. In strict terminology, these cases without any necroses should not be termed PVL . This diffuse-lesion-only may be the least severe form of cerebral white matter injury, but because its MRI appearance is likely identical to the least severe form of PVL, that is, with microscopic necroses, distinction in vivo is not currently possible . Whether these infants consistently exhibit diffuse signal abnormality on MRI is unknown. Moreover, whether infants with the diffuse gliotic component without any necrotic component subsequently exhibit the neuronal/axonal dysmaturational effects of the encephalopathy of prematurity also is not known. The particular potential importance of diffuse white matter gliosis without focal necroses relates not only to its high frequency in neuropathological studies of premature infants, but also to the recent observations of Buser et al., who not only confirmed the high frequency but who also showed in cerebral white matter the characteristic excess of pre-OLs and their maturational arrest , as observed in the diffuse component of PVL. These findings suggest that such infants in vivo could develop the impairment of myelination and perhaps also the secondary dysmaturational effects on neuronal/axonal structures consequent to disrupted myelination (see Chapter 14 ). The important point in this context is that accurate identification of the diffuse white matter cellular abnormalities in vivo in the neonatal period currently is not clearly possible . Experimental data based on imaging at 11.7T suggest potential for identifying and quantifying white matter gliosis (as well as microscopic necrosis). However, the imaging was carried out ex vivo , and the safety of imaging human preterm brain at 11.7T has not been established.
Cranial Ultrasonography.
Cranial ultrasonography is of great value in diagnosis ( Tables 16.6–16.8 ). The cysts of cystic PVL are readily visible by cranial ultrasonography (see Table 16.6 ; Figs. 16.3–16.5 ). They are located primarily just lateral to the atria of the lateral ventricles, and extend anteriorly, and to some extent posteriorly, with increasing severity ( Fig. 16.6 ). They are sometimes only visible for a few weeks and may have fully resolved by term equivalent, but their presence is predictive of subsequent cerebral palsy. Their resolution is likely due to development of a gliotic scar with collapse of the cyst (see Chapter 14 ; Fig. 16.7 ). As a result, their manifestation at term equivalent may be subtle, consisting of mild to moderate ventricular dilatation and an irregularly contoured ventricular wall.
ULTRASONOGRAPHIC APPEARANCE | TEMPORAL FEATURES | NEUROPATHOLOGICAL CORRELATION |
---|---|---|
Echogenic foci, bilateral, posterior > anterior | First week | Necrosis with congestion and/or hemorrhage, (size > 1 cm) |
Echolucent foci (“cysts”) | 1–3 weeks | Cyst formation secondary to tissue dissolution (size > 3 mm) |
Ventricular enlargement, often with disappearance of “cysts” | ≥2–3 months | Deficient myelin formation; gliosis, often with collapse of cyst |
CRANIAL ULTRASOUND FINDING | MRI FINDING AT TERM | ||
---|---|---|---|
NORMAL | WHITE MATTER SIGNAL ABNORMALITY | CYSTIC CHANGE | |
Normal or transient echodensity ( n = 74) | 48 | 25 | 1 |
Prolonged echodensity ( n = 19) | 10 | 9 | 0 |
Echolucencies ( n = 3) | 0 | 0 | 3 |
Echolucencies on US are sensitive and specific for focal cystic lesions |
Echodensities on US may be transient (<7 days), prolonged >7 days, or evolve to lucencies |
Transient echodensities are generally not predictive of WM abnormality on MRI at term |
Echodensities that are prolonged (>7 days) or severe or apparent after the first week of life are variably predictive of WM abnormality on MRI at term |
Mild or moderate WM signal abnormalities on MRI at term are poorly predicted by cranial ultrasonography; approximately 70% of noncystic white matter abnormality on MRI at term is not detected by cranial ultrasonography |
The ultrasonographic imaging correlates of noncystic PVL are generally not obvious (see Tables 16.7 and 16.8 ). Some data suggest that cerebral white matter echodensity at least as echogenic as the choroid plexus and persisting for at least 7 days is significant. Further, the presence of white matter inhomogeneity or a patchy appearance on ultrasonography should also alert the clinician to potential white matter abnormalities ( Fig. 16.8 ). This patchy appearance can sometimes be hemorrhagic in origin, and a combination of diffusion- and susceptibility-weighted MRI can help identify a hemorrhagic component. Although PVL is principally a nonhemorrhagic lesion, occasionally secondary hemorrhage can be dramatic ( Fig. 16.9 ).
Magnetic Resonance Imaging.
The focal necrotic/cystic component of PVL, observed well on cranial ultrasound, is readily demonstrated by MRI as well (see Table 16.5 ). However, the much more common moderate (noncystic) forms of PVL often also are detected by MRI and generally not by cranial ultrasonography (see Table 16.7 ). Indeed, the high frequencies of noncystic cerebral white matter abnormality, manifested either as focal punctate white matter lesions or, even more commonly, of the mildest form of PVL (with microscopic necroses), manifested only as diffuse MRI signal change, were unexpected until the application of MRI (see Table 16.5 ). The frequency of the diffuse abnormality on MRI increases as a function of postnatal age . In one series with serial MRI scans, the finding of diffuse MRI signal abnormality in premature infants with a median gestational age of 27 weeks increased from 21% in the first postnatal week, to 53% over the next several weeks, to 79% at term equivalent. In a later prospective study of 100 premature infants, 64 exhibited white matter signal abnormality at term.
The neuropathological correlates of the diffuse white matter signal abnormality, known as diffuse excessive high signal intensity (DEHSI), are unclear. A reasonable speculation is that the abnormality reflects the diffuse gliotic (astrogliosis and microgliosis) component of PVL. It is seen best on T 2 -weighted images at term equivalent age and is a common finding (see earlier). While these white matter signal intensity changes are associated with increased water diffusion coefficient values on diffusion imaging, the qualitative identification of signal changes on T 2 -weighted images is subjective. Further, recent studies have failed to identify a relationship between these signal changes and outcome at either 18 or 30 months of age. However, the absence of a later clinical correlate to DEHSI does not necessarily mean that a degree of white matter injury isn’t present. Indeed, in the neuropathological series referred to earlier, the focal necrotic component was less than 1 mm in most cases and likely below the resolution of clinical MRI scanners. Moreover, as noted earlier, in 42% of the entire series of autopsied premature infants diffuse gliosis without focal necrosis was present. Whether the subsequent neuronal/axonal abnormalities observed in the encephalopathy of prematurity and likely important for long-term outcome were present is unknown. Moreover, the lack of later clinical abnormalities also could reflect the beneficial effects of plasticity.
Other potential MRI correlates of diffuse cerebral white matter injury in the neonatal period include disturbances of white matter structure detected via diffusion anisotropy maps ( Fig. 16.10 ) and abnormalities of 1 H spectroscopy, with both involving areas of white matter that may appear normal on conventional, T 1 – and T 2 -weighted, imaging.
Neuroimaging of Neuronal/Axonal Components in the Encephalopathy of Prematurity
The neuronal/axonal components of the encephalopathy of prematurity are difficult to visualize by neuroimaging in the acute period. However, over the ensuing weeks such abnormalities become prominent and are detectable by advanced MRI methods (see later).
Prognosis and Clinicopathological Correlations
Difficulties of Delineating Prognosis and Clinicopathological Correlations in Premature Infants
Delineation of prognosis and, in particular, clinicopathological correlations attributable to the encephalopathy of prematurity is hindered by (1) in vivo identification of the encephalopathy, (2) the concurrence of brain abnormality secondary to a variety of deleterious postnatal events unrelated to the encephalopathy of prematurity, and (3) definition of the specific regions affected—especially those involved in dysmaturation subsequent to the initial destructive effects. Concerning the in vivo identification of the encephalopathy , the central feature is cerebral white matter injury (see earlier and Chapter 14 ). At present, identification of the white matter lesion of the encephalopathy of prematurity in vivo is accomplished most definitively by detection of the focal necrotic component of PVL . Unfortunately, the difficulty of such detection is related to the relatively small proportion of cases in which the focal necrotic component of PVL would be expected to be detectable by clinically available conventional MRI scanners ( Table 16.9 ). As noted earlier, in the neuropathological series cited, 41% ( n = 17) had PVL, and among this PVL group, fully 82% ( n = 14) had focal necrotic lesions that were smaller than 1 mm and visible only by microscopy. Thus only 3 of the 17 infants (8%) with PVL had focal necrotic lesions likely readily detected by MRI. The remaining 14 infants (92%) with PVL had microscopic lesions predicted to be below the detection of clinically used MRI scanners. However, it is possible that such lesions could exhibit surrounding inflammatory changes that allow them to be detectable, at least early and transiently . For example, in a recent report of 112 premature infants with punctate white matter lesions on MRI, approximately one-third were only visible on an early scan and were no longer apparent at term (see Table 16.9 ). Similarly, in a recent study in which 54 infants underwent MRI studies at 32 weeks’ postmenstrual age and at term equivalent, the white matter injury (consisting of cysts or increased focal signal intensity in the periventricular area on T 1 -weighted imaging) appeared less severe on the MRI study at term equivalent age in 24 infants. These findings suggest that a portion of the injury apparent at 32 weeks was no longer detectable by MRI at term equivalent in nearly half the infants . In two recent large studies of premature infants (<33 weeks’ gestational age and <28 weeks’ gestational age) MRI at term equivalent age did detect moderate/severe WMI in nearly 20%. Nevertheless many studies based on conventional MRI likely underestimate infants with white matter injury as well as the neuronal/axonal defects of the encephalopathy of prematurity (see Chapter 14 ). This concern can be allayed partially by detection of white matter microstructural impairment by diffusion-based MRI at term equivalent age or later (see Fig. 16.10 and see later). Currently, the availability of such advanced magnetic resonance (MR) methodologies is limited.
In vivo identification of the cerebral white matter injury—microscopic areas of necrosis are very frequent and are invisible to conventional MRI |
Common indicators of white matter injury detectable by MRI, for example, punctate white matter lesions, may be apparent early in the neonatal course but disappear by term equivalent age |
In vivo identification of neuronal/axonal deficits are very difficult in the acute/subacute period and, later, require advanced MRI methods for detection |
Many other concurrent factors, related to drugs, pain, stress, nutrition, experiential events, independently may have deleterious effects on the developing premature brain |
Concerning the concurrence of brain abnormality secondary to other deleterious postnatal factors , many studies do not systematically address the effects of such factors. The latter may include specific drugs (e.g., glucocorticoids, narcotics, sedatives), pain, stress, nutrition, experiential factors, infection, etc.
Concerning definition of the specific brain regions affected , particularly cerebral cortex and other gray matter structures, the principal difficulties relate to the dysmaturational nature of the brain abnormalities (relating to impaired organizational developmental events—see Chapter 7 ), their later occurrence, and the advanced MRI techniques required for detection (e.g., volumetric MRI, diffusion tractography, cerebral cortical surface-based measures, functional MRI; see Table 16.9 ). Many follow-up studies do not include such measures either in the neonatal period or later.
Thus, in the sections to follow, although we emphasize outcomes in premature infants with clearly defined white matter injury with evidence for focal necroses or, in some studies, evidence for microstructural white matter injury, and presumably therefore the encephalopathy of prematurity, we also discuss other large-scale studies of premature infants without imaging evidence of overt injury with focal necroses, with the presumption, based in part on the neuropathological studies, that the encephalopathy is present and invisible to the imaging modalities used. Relatively strong correlations can be found between some outcomes, the degree of brain injury, and its location in connections to and from primary motor or sensory cortices (see sections on spastic diplegia and visual impairment). These correlations result because the involved cerebral regions include areas of eloquent cortex with clearly defined afferent and efferent pathways and functional correlates. In contrast, the imaging correlates of cognitive and behavioral impairment, which are common in preterm children, are not so discrete, likely because these functions are anatomically more widely distributed. Consequently, as described below, these correlates often reflect an overall burden of injury rather than injury to a specific brain area. Such outcomes may be related to abnormality in more than one type of brain tissue (white matter, cortex, deep nuclear gray matter). In some instances, an overall global abnormality score derived from assessment of the entire brain shows the strongest relation to outcome, although such scores may not provide precise clinicopathological, correlative information.
Clinicopathological Correlates
The major long-term correlates of the encephalopathy of prematurity include motor deficits—spastic diplegia and less severe motor deficits—and a variety of cognitive, behavioral, attentional and socialization defects (see Table 16.2 ). These neurological disturbances relate in varying degrees to the cerebral white matter injury and to the associated deficits of cerebral cortex, thalamus, basal ganglia, and cerebellum, as outlined next.
Motor Deficits
Motor deficits observed later in premature infants are common, but over the past decades these deficits have declined, particularly in severity. The motor deficits consist of the major spastic motor deficits, often categorized as cerebral palsy , and relatively minor motor deficits involving coordination and other more subtle aspects of motor function, sometimes referred to as developmental coordination disorder . We discuss the major and minor motor deficits next.
Spastic Diplegia.
Premature infants may exhibit a variety of major motor deficits related to PVL, severe IVH (see Chapter 24 ), and stroke (see Chapter 21 ), among other pathologies. In the context of this chapter on the encephalopathy of prematurity, the principal major motor deficit is spastic diplegia . This motor disturbance has as its central feature spastic paresis of the extremities with affection of lower more than upper limbs. The incidence of this motor deficit has declined markedly in the past two decades and is generally approximately 2% to 3%, although in the extremely preterm infant the incidence can be as high as 10%.
Two major lines of evidence indicate that the focal necroses of PVL result in spastic diplegia and its variants. First, the topography of the focal lesions includes the region of cerebral white matter traversed by descending fibers from motor cortex, and those subserving function of lower extremities are more likely to be affected by the periventricular locus of the necrosis ( Fig. 16.11 ). More severe lesions, with lateral extension into the centrum semiovale and corona radiata, would be expected to affect upper extremities and intellectual functions as well. Indeed, patients with spastic diplegia with significant involvement of upper extremities exhibit other manifestations of more severe cerebral disturbance, including intellectual deficits ( Table 16.10 ).
INTELLECTUAL FUNCTION | SPASTIC DIPLEGIA a ( n = 81) (%) | SPASTIC QUADRIPLEGIA a ( n = 56) (%) |
---|---|---|
Normal or IQ ≥70 | 68 | 14 |
Moderate mental retardation | 15 | 21 |
Severe mental retardation | 17 | 54 |
a Spastic diplegia—lower extremities affected more than upper extremities; spastic quadriplegia—lower and upper extremities equally affected.
A second line of evidence linking spastic diplegia and focal PVL, related to the first, is that the ultrasonographic and MRI correlates of the focal necrotic component of PVL, especially cystic PVL, are associated with spastic diplegia. The severity and extent of injury, as manifested by cystic change or ventricular dilation or both, are correlated with more severe involvement of lower limbs, prominent involvement of upper limbs, and impairment of cognitive function. Further, in a study in which the location of cysts and/or signal abnormality on MR was compared with motor outcome, cysts located more anteriorly, near the corticospinal tracts, were most strongly associated with motor deficits (see Fig. 16.6 ). The motor deficits in premature infants with mild spastic diplegia may disappear in the first several years of life, especially if the white matter lesions are noncystic by ultrasonography.
In addition to the evidence cited above indicating that spastic diplegia is caused by periventricular injury to descending corticospinal tracts, injury to thalamocortical sensory afferents may also play a role in the motor deficits associated with PVL. Several studies using diffusion tensor imaging with diffusion anisotropy measures (see Chapter 10 ) to evaluate white matter integrity found correlations between the degree of white matter abnormality in thalamocortical tracts and motor deficits in older children who had been born prematurely. Thus it has been hypothesized that disruption of sensorimotor loops involved in motor control plays an important role in the motor deficits associated with PVL. Nevertheless, in a recent report in which both corticospinal and thalamocortical tracts were assessed, correlation of motor dysfunction in spastic diplegia was greater for impairment of the former than the latter.
Other Motor Disturbances.
At least one-half of preterm infants exhibit motor disturbances despite the absence of cerebral palsy ( Table 16.11 ). These include difficulties in gross and/or fine motor skills, involving especially balance, visual motor integration, hand-eye coordination, manual dexterity, and related motor impairments. These disturbances are manifest in infancy as delayed motor milestones; at school age with impairment in activities ranging from running, ball skills, and drawing; and in adolescence and adulthood with clumsiness and dyscoordination. Although these deficits are minor in comparison to cerebral palsy, they are much more common and may affect quality of life.
Early difficulties in: |
|
Later difficulties in: |
|
The clinicopathological correlates of these disturbances are likely multiple. In keeping with a relation to the white matter injury of the encephalopathy of prematurity, long-term follow-up studies of preterm infants with white matter signal abnormalities detected on conventional (T 1 – and T 2 -weighted) MRI at term equivalent were strongly predictive of motor impairment at ages 2 and 5 years. Further, diffusion abnormalities of white matter, including the internal capsule and corticospinal tracts, have been associated with similarly abnormal motor outcomes. Whether gray matter structures involved in the encephalopathy of prematurity, for example, basal ganglia and thalamus, are involved seems likely, but has not been studied specifically. Recent work suggests importance also for cerebellar impairment. More data are needed on this important issue.
Neurodevelopmental (Nonmotor) Deficits
Neurodevelopmental, nonmotor deficits now dominate the long-term neurological correlates of the encephalopathy of prematurity. These can be considered in terms of cognitive, behavioral, socialization, and visual deficits ( Table 16.12 ).
Cognitive |
Overall intellectual disability |
Executive dysfunction |
Language impairment |
Behavior |
Attentional dysfunction |
Socialization |
Autistic phenomena |
Visual |
Cerebral visual impairment |
Cognitive Deficits.
Cognitive performance involves a complex series of functions that can be parsed in many ways. In this section, we review overall intelligence quotient (IQ) measures (often from younger populations) followed by outcome measures involving more specific cognitive functions, including language and executive function (EF) ( Table 16.13 ).
OUTCOME MEASURE | WHITE MATTER ABNORMALITY AT TERM a | ||||
---|---|---|---|---|---|
NONE ( n = 47) | MILD ( n = 85) | MODERATE ( n = 29) | SEVERE ( n = 6) | P | |
MDI cognitive score | 92 | 85 | 80 | 70 | <.001 |
PDI psychomotor score | 95 | 91 | 80 | 56 | .008 |
Severe motor delay (%) | 4 | 5 | 26 | 67 | <.001 |
Cerebral palsy (%) | 2 | 6 | 24 | 67 | <.001 |
Neurosensory impairment (%) | 4 | 9 | 21 | 50 | .003 |
a Severity of white matter abnormality graded according to a numerical scale based on nature and extent of white matter signal abnormality, white matter volume loss, cystic abnormalities, ventricular dilation, and thinning of the corpus callosum.
Concerning overall cognitive performance , fully 30% to 50% of very preterm survivors exhibit cognitive deficits, and as a group, preterm infants have lower developmental quotients than their term-born counterparts. In a meta-analysis published in 2002, the weighted mean difference in cognitive scores of preterm and term-born control infants was 10.9 (95% CI 9.2 to 12.5). This difference was directly proportional to gestational age or weight at birth, with values ranging as high as 22.7 (95% CI 16.3 to 29.1) for infants born weighing less than 750 g. A 10-point reduction in IQ has significant meaning for an individual child, but also has meaning at a group level. For example, if one assumes, as an approximation, that the standard deviation of IQ values is similar between term and preterm children, a 10-point reduction in the mean value (from 100 to 90) corresponds to an increase in the fraction of children with IQ below 85 from 16% to 37%, and an increase in the fraction with IQ below 70 from 2.5% to 9%. This shift in distribution has social consequences, and it is well known that preterm children require a disproportionate amount of follow-up resources.
Concerning the clinicopathological correlates of the cognitive deficits in premature infants, consistent with the concept of the encephalopathy of prematurity, white matter injury appears central. A relation of severe cognitive deficits to white matter involvement is apparent in infants with cystic PVL and spastic involvement of both upper and lower extremities, as described earlier (see Table 16.10 ). Notably, most infants with noncystic PVL exhibit only minor motor deficits, but prominent cognitive disturbance. Involvement of cerebral white matter fibers subserving visual, auditory, somesthetic, and associative functions may be crucial in this context. Indeed, the peritrigonal region, a site of predilection of PVL, is a region containing a high concentration of interhemispheric callosal commissural fibers, intrahemispheric associative fibers, and ascending (thalamocortical) and descending (cortical to deep nuclear structures and to brain stem/cord) projection fibers. In an assessment of the relationship between the amount of white matter involved with PVL and cognitive outcome, the involvement of frontal white matter particularly predicted adverse cognitive and motor outcomes (see Fig. 16.6 ). However, this regional distinction is not dramatic and has not been emphasized by others.
The importance of white matter injury in relation to cognitive outcome was suggested by a series of studies that reported an association of impaired neurodevelopment in premature infants studied in later infancy, childhood, and adolescence in whom neuroimaging during the neonatal period showed white matter signal abnormality, ventricular dilation, and qualitative measures of diminished white matter volume. The largest well-characterized study to date ( n = 167) of VPT (<30 weeks’ gestation) showed clearly the relationship between the frequency and severity of these neonatal MRI measures (obtained at term equivalent age) and subsequent cognitive motor deficits (see Table 16.13 ). The increasing severity of white matter injury was accompanied by such abnormalities of gray matter as increased size of the subarachnoid space and impaired gyral maturation. The likely relation of the latter dysmaturation to primary injury to white matter was detailed in Chapters 7 and 14 . Since the seminal work just described, there have been a large number of studies principally confirming the earlier observation. White matter abnormality can also be quantified with diffusion imaging, particularly through measures of diffusion anisotropy (see Chapter 10 ). For example, in a study of preterm children with follow up at 2 years, cognitive scores were correlated with anisotropy values in the corpus callosum.
Consistent with the concept that primary cerebral white matter injury is related to the secondary developmental disturbances of cerebral cortex, thalamus, and basal ganglia seen in premature infants (see Chapter 14 ), a particularly detailed MRI study defined a common neonatal image phenotype that appeared to predict adverse neurodevelopmental outcome in children born preterm. Based on a study of 80 preterm infants (mean gestational age 29 weeks) by MRI at term equivalent age, Boardman and collaborators delineated the common image phenotype as diffuse white matter injury and tissue volume reduction in the thalamus, globus pallidus, periventricular white matter, corona radiata, and central region of the centrum semiovale. The abnormal image phenotype was associated with reduced median DQ (DQ = 92) at 2 years compared with control infants (DQ = 112). In a similar study of adolescent children, Soria-Pastor et al. also found that lower white matter volume was associated with IQ and processing speed.
Because our current concept of the encephalopathy of prematurity involves primary white matter injury leading to secondary dysmaturation of gray matter structures (see Chapter 14 ), it would be predicted that imaging studies of preterm infants later in life would show evidence of such developmental disturbances. Gray matter tissue signal abnormalities in preterm infants are less common in the neonatal period than are white matter signal abnormalities, perhaps consistent with the uncommon occurrence of acute neuronal injury. Gray matter abnormality is more typically manifest near term equivalent age as alterations of cortical folding and/or enlarged extracerebral spaces . As discussed in Chapter 7 , dramatic changes in cortical folding take place during the third trimester of gestation. This process can be disrupted in preterm infants. For reasons that have not been fully elucidated, these cortical folding abnormalities most commonly involve the temporal and inferior frontal areas as well as the cingulate sulcus. In a study of 167 VPT, gray matter abnormalities were found in half of the infants and consisted of abnormal/immature cortical folding patterns and/or enlarged subarachnoid space. These abnormalities were associated with an increased risk of severe cognitive delay, psychomotor delay, and cerebral palsy at age 2 years, but the association was less robust than that with white matter abnormalities in the same study. The potential links between cerebral white matter injury and cortical folding abnormalities were discussed in Chapter 7 , but may involve impairment of late migrating GABAergic neurons to superficial layers of cerebral cortex or of tension generated by underlying developing white matter. Perhaps more promising markers of cerebral cortical maturational impairment and subsequent outcome will include the cortical folding measures outlined recently by Shimony et al. (see Chapter 7 ). In a study of neurodevelopmental outcomes in preterm children in which correlations were sought between abnormalities on MRI at term equivalent age and outcome at age 7 years, T 1 – and T 2 -weighted MRI studies were scored for signal abnormality and/or volume loss in white matter, cortex, deep nuclear gray matter, and cerebellum. Higher global, deep gray matter and cerebellar as well as white matter abnormality scores were related to poorer IQ and motor function ( Fig. 16.12 ). Notably, abnormalities of the area of basal ganglia showed a strong relation to cognitive outcome. While area reduction could be related to direct injury to deep nuclear gray matter, it is more likely that basal ganglia area reduction reflects a disruption of reciprocal connections between basal ganglia and cortex as a consequence of white matter injury or cortical dysmaturation or both (see Chapter 14 ).
In addition to findings on conventional MRI, MR volumetry (see Chapter 10 ) has also been applied to evaluate preterm children and outcomes. Widespread alterations in cerebral volumes have been described for preterm infants imaged at term equivalent age, and a number of studies have related volume changes with neurodevelopmental outcome. At short-term follow-up (<2 years), neurodevelopmental disability was associated with volumetric reductions in cerebral white matter, cerebral cortex, deep nuclear gray matter, hippocampus, total cerebral tissue, and cerebellum.
EF is a broad term that refers to coordination of many interrelated processes and involves purposeful, goal-directed behavior that is instrumental in cognitive, behavioral, emotional, and social functions. While there is not yet consensus on the exact components of EF, it may be considered to include cognitive flexibility, goal setting, attentional control, and information processing. Executive dysfunction, then, is not a unitary disorder, but reflects a range of impairment phenotypes.
One of the functional implications of executive dysfunction is poor academic performance (which may also be caused by low IQ), and a number of studies have shown poorer academic performance for preterm children on standardized testing. Deficits in academic performance may also be manifest as learning disability. In a study of 75 children weighing less than 800 g at birth who had a verbal or performance IQ ≥85, 65% of preterm children met criteria for learning disability, as compared with 13% of the control group. Findings on subtests were consistent with the large body of evidence showing that academic underachievement arises, at least in part, from executive dysfunction.
Concerning clinicopathological correlations, the association between imaging findings and executive/academic dysfunction in preterm children has been evaluated in multiple studies. In the study noted earlier with outcomes at age 7 years (see Fig. 16.12 ), higher cerebral white matter, deep gray matter, and global abnormality scores were related to spelling and math computation. Studies focused on white matter injury have also noted associated impairments in executive functioning, verbal and visuospatial working memory, and learning. Overall the frequent concurrence of cerebral white matter abnormality with disturbances of gray matter structures is consistent with the central concept of the encephalopathy of prematurity.
Language delay is common in preterm children (see Table 16.12 ). The language and communication problems are often attributed to delayed development with the expectation of later catch-up. However, meta-analysis indicates that language deficits persist in preterm children with a severity comparable to that documented in other cognitive domains. The language deficits affect quality of life, including friendship quality, reading skills, and overall academic achievement. Language function can be divided into simple (vocabulary words and short phrases) and complex (wording, meaning of concepts, use of verbs, relational terms, and complex sentences). In a meta-analysis, preterm children were found to lag behind term control children in both simple (0.5 SD, 95% CI 0.3 to 0.6) and complex (0.6 SD, 95% CI 0.4 to 0.8) language measures.
When considering the imaging correlates of language dysfunction, current concepts indicate that the anatomical substrate of language function involves widely distributed areas. Functional MRI studies show that language networks are detectable in preterm infants, despite the fact that the infants will not have any fluent speech for more than a year. The imaging correlates of language impairment in preterm children are likely multiple, but white matter disturbance is identified commonly. For example, white matter injury has been associated with impaired language skills. Cerebellar lesions in the absence of overt cerebral lesions have also been associated with abnormalities of receptive and expressive language. Recall, however, that most cerebral white matter injury in premature infants may be below the resolution of conventional MRI (see earlier). Further, reduced corpus callosum volumes, consistent with white matter injury, have been related to impaired verbal fluency.
Behavioral Disturbances.
Especially common sequelae in premature infants involve behavioral issues, especially attention-deficit/hyperactivity disorder ( ADHD ). ADHD is relatively common among preterm children, with prevalence rates of 10% to 20%. In a recent meta-analysis, preterm children had a relative risk of 2.64 compared with term-born children. The prevalence also varies with degree of prematurity, and in one study was 17% for infants born weighing less than 750 g as compared with 6% in infants weighing 750 to 1499 g at birth. ADHD has been associated with such neonatal medical factors as chronic lung disease, sepsis, and necrotizing enterocolitis, as well as intracranial hemorrhage and white matter injury. It has also been suggested that reduction of perinatal systemic inflammation could reduce the incidence of ADHD. Notably, systemic inflammation is an important precipitant of cerebral white matter injury (see Chapter 15 ). There are relatively few studies linking imaging abnormalities with attentional difficulties in preterm children, but one study comparing MRI at term equivalent age with outcome at age 7 years found that the strongest link with attention difficulties was abnormalities in deep nuclear gray matter. The latter are commonly associated with cerebral white matter injury in the encephalopathy of prematurity.
Socialization Deficits—Autism Spectrum Disorders.
Approximately 20% of preterm toddlers have abnormalities on early screening tests for autism spectrum disorder (ASD), such as the Modified Checklist for Autism in Toddlers (MCHAT), suggesting that they are at high risk for ASD. Major motor, cognitive, visual, and hearing impairments may lead to false- positive screening tests, and these impairments may account for more than half of the positive MCHAT screens in extremely low gestational age newborns. Nevertheless, even after those with such impairments are eliminated, 10% of children—nearly double the expected rate—screen positive. The perinatal clinical correlates of ASD and other social/behavioral issues in preterm infants are not yet fully delineated. However, the risk of ASD does increase with the degree of prematurity, either with or without intellectual disability. From a neuroimaging standpoint, ASD has been associated with cystic white matter lesions and cerebellar abnormalities during the perinatal period, although in studies with relatively small numbers of subjects.
Visual Deficits.
A number of injuries can lead to visual impairment in preterm children, ranging from retinopathy of prematurity (ROP) through injury to white matter visual pathways, thalamus, and cerebral cortex. In this section, we focus primarily on visual impairment caused by brain injury. Much of the visual impairment found in preterm children can be classified as cortical or cerebral visual impairment (CVI), which is defined as bilateral impairment of visual acuity due to damage to cerebral visual areas. In a study of 105 preterm infants and 67 control infants, 24% of the preterm children met criteria for CVI, compared to 7% of controls (OR 3.86, 95% CI: 1.40 to 10.70). Several studies have evaluated the association between brain injury and visual impairment. Perhaps not surprisingly, PVL has a strong association with visual impairment, as the primary area of injury includes the optic radiations (geniculocalcarine tracts) and visual association fibers. More severe PVL correlates with poorer future vision, and lesions of the peritrigonal white matter and optic radiations, as well as of the occipital cortex, have been associated with abnormality of visual acuity and function.
CVI, though defined on the basis of visual acuity, is also associated with impaired visual perception and visual-motor integration. Geldof et al. have proposed that these impairments are related to injury involving occipital-parietal-frontal neural circuitries. These circuitries are mediated by cerebral white matter regions particularly likely to be affected in cerebral white matter injury in premature infants. Consistent with the importance of cerebral white matter injury in recovery is the finding that only 42% of children with PVL and CVI show improvement in visual function, a proportion considerably lower than the 78% of a heterogeneous group of infants with primarily striate cortical injury.
A number of studies have evaluated the relationship between the quality of MRI diffusion parameters of the geniculocalcarine tract (usually fractional anisotropy, see Chapter 10 ) and visual function. In general, higher anisotropy values corresponded to better visual function. In one study of 142 preterm children and 32 control children who were evaluated at age 7 years, diffusion abnormalities were also found in association with white matter injury on conventional MRI and with ROP. The association of abnormalities of the geniculocalcarine tract with ROP suggests that cerebral white matter changes not only can cause visual impairment, but can be caused by other abnormalities. In the case of ROP, it has been postulated that the abnormalities of the geniculocalcarine tract are a consequence of trans-synaptic effects. Other studies concerning structure function relationships include a volumetric study in which reduced occipital regional volumes were associated with impaired visual function.
Management
Management of the encephalopathy of prematurity focuses especially on the central and initial neuropathological feature, that is, cerebral white matter injury. Prevention of the diverse dysmaturational events that occur in the weeks to months subsequent to the initiating white matter injury and during the remarkable series of complex developmental events normally occurring in brain (see Chapter 7 ) remains largely unknown and will only be discussed later in this section (see section on neurorestorative interventions ). Thus the focus in this discussion of management will be prevention and treatment of cerebral white matter injury in the premature infant. As discussed in detail in Chapters 13 and 15 , the two principal upstream mechanisms leading to this injury are hypoxia-ischemia and infection-inflammation . Thus the major emphases of management relate to these two mechanisms. The basic elements of management are outlined in Table 16.14 .
Antenatal Interventions
Prevention of Premature Birth
Prevention of premature birth would be the most decisive way to prevent cerebral white matter injury of prematurity ( Table 16.14 ). Attempts at prevention have emphasized (1) identification of the woman at high risk for premature delivery, (2) management of such a woman with a combination of approaches, and (3) early treatment of premature labor, primarily with tocolytic agents (see Chapter 24 ). Overall, results thus far have not been dramatically beneficial.
Antenatal |
|
Newborn resuscitation |
Ventilation |
|
Perfusion |
Glucose |
Seizures |
Indomethacin (?) |
Neuroprotective interventions |
Neurorestorative interventions |
Antenatal Magnesium
Magnesium sulfate has been used for many years in obstetrics as a tocolytic agent for preterm labor and as therapy for preeclampsia. The evidence of its effectiveness for the latter purpose is stronger than that concerning its role as a tocolytic (see Chapter 24 ). Particular interest for the maternal use of magnesium sulfate in the prevention of neurological deficits in infants born prematurely began with a report that only 7.1% of VLBW infants with later cerebral palsy were exposed to maternal magnesium sulfate versus 36% of a control group. In a subsequent study of approximately 1000 premature infants, those whose mothers received magnesium sulfate had a lower prevalence of cerebral palsy (0.9%) than those whose mothers did not receive this agent (7.7%). However, subsequent evidence regarding benefit for magnesium sulfate for prevention of cerebral palsy or associated brain lesions or both has not been consistently positive. Meta-analyses have shown that antenatal magnesium sulfate administered for neuroprotection in preterm infants is associated with a reduction of cerebral palsy at a corrected age of 18 to 24 months, but studies of longer-term outcomes have failed to show benefit.
Experimental studies concerning a beneficial role for magnesium in prevention or amelioration of hypoxic-ischemic death also have yielded conflicting results. Thus, in perinatal hypoxic-ischemic models in the rat, piglet, and fetal lamb, magnesium sulfate treatment either during or immediately following the insult did not ameliorate adverse biochemical, neurophysiological, or neuropathological effects. Nevertheless, other experimental work supported the potential value of magnesium by several mechanisms (i.e., antiexcitatory amino acid [impairs release, blocks the N -methyl- d -aspartate (NMDA) receptor], antioxidant [essential for glutathione biosynthesis], anticytokine [decreases levels of inflammatory cytokines], and antiplatelet [decreases platelet aggregation] effects). Perhaps the most likely beneficial effect of magnesium relates to its strong vasodilatory properties, which can lead to an increase in uteroplacental blood flow and perhaps also to improved fetal perfusion. Such effects also could decrease the likelihood that the infant postnatally would experience a pressure-passive cerebral circulation and thereby cerebral ischemia and periventricular white matter injury (see Chapter 13 ).
A recent large randomized trial suggests that the gestational age of the infant may be critical in determining whether antenatal magnesium sulfate is beneficial. Thus, in infants born at less than 32 weeks of gestation, 82% of the preterm infants in the study, magnesium sulfate was associated with a reduction in occurrence of echolucency or echodensity. Moreover, a reduced risk of cerebral palsy at 2 years of age (OR 0.63, 95%, CI 0.42 to 0.95) was observed and could be partially accounted for by the ultrasonographic findings. More data are needed on these issues.
Antenatal Steroids
Antenatal administration of glucocorticoids may be useful in prevention of cerebral white matter injury in premature infants (see Table 16.14 ). Several studies using cranial ultrasonography for detection of largely cystic PVL have shown a beneficial effect. Antenatal steroids also have a clear benefit in reducing the incidence of germinal matrix-intraventricular hemorrhage. The beneficial effects of steroids occur after a complete course and preferably, with betamethasone. Perhaps related to these effects, a recent review noted that a single course of antenatal steroids was associated with a reduced risk of cerebral palsy (RR 0.83, CI 0.74 to 0.93), psychomotor development index less than 70 (RR 0.79, CI 0.73 to 0.85), and less overall severe disability (RR 0.79, CI 0.73 to 0.85).
The basis for the beneficial effect of antenatal steroids likely relates at least in part to the long-established enhancement of pulmonary maturation and the consequent decrease in respiratory distress syndrome. Treated infants have improved cardiovascular stability, with less hypotension postnatally and less need for blood pressure support. This beneficial postnatal hemodynamic effect could relate to less likelihood of impaired cerebrovascular autoregulation because of improved placental blood flow (see Chapter 24 ). The possibility also exists that glucocorticoids have a beneficial effect on brain maturation, especially the periventricular vasculature (see Chapter 24 ).
Not all infant populations are benefitted similarly by antenatal glucocorticoids. For example, a recent study showed no difference in respiratory distress syndrome or IVH after antenatal corticosteroids. Moreover, certain steroid preparations, for example, dexamethasone, have been associated with adverse effects on brain development especially when used for prolonged periods postnatally (see Chapters 4 and 7 ).
Antenatal Antibiotics and Other Antiinflammatory Agents
Antibiotics.
In a subset of infants, maternal intrauterine infection and fetal systemic inflammation appear important in pathogenesis of cerebral white matter injury (see Table 16.14 ; see Chapter 15 ). Moreover, maternal intrauterine infection is a major cause of spontaneous preterm labor. A study of over 4000 women in spontaneous preterm labor compared administration of erythromycin and/or amoxicillin-clavulanate with that of placebo. At age 7 years the children administered either antibiotic regimen showed no benefit in functional attainment , those administered erythromycin showed an increase in functional impairment, and those administered either antibiotic regimen showed an increase in risk of cerebral palsy . Thus the routine use of antibiotics is not of apparent benefit in mothers in spontaneous labor. In a separate study, the use of erythromycin in preterm labor with premature rupture of membranes led to a small reduction in adverse short-term neonatal outcome, but the adverse effect of erythromycin in the study just described raises questions about the merit of this practice. Note that these data do not address the antibiotic treatment of overt chorioamnionitis in mothers with premature rupture of membranes or mothers with positive Group B streptococcal cultures (see Chapter 35 ).
N -Acetylcysteine.
Another antenatal attempt to combat the effects of intrauterine infection/systemic inflammation involves the use of N -acetylcysteine (NAC; see Table 16.14 ). NAC is a free radical scavenger that, in experimental models of chorioamnionitis, has been shown to cross the blood-brain barrier, decrease oxidative stress, and exhibit multiple antiinflammatory effects. In a recent study of mothers with chorioamnionitis, 22 were randomized to receive either intravenous NAC or saline before delivery and for 2.5 days past delivery. In saline-treated infants cerebrovascular autoregulation was impaired, but in NAC-treated infants this critical parameter, a potential precursor to hypoxic-ischemic injury, was preserved. Whether this apparent beneficial effect will lead to prevention of brain injury or dysfunction will require a larger study. Nevertheless, the data are of interest.
Optimal Management of Labor and Delivery
Potentially deleterious effects of labor and delivery relate in considerable part to the easily deformed, particularly compliant skull of the premature infant (see Table 16.14 ). Such deformations could lead to such cerebral hemodynamic disturbances as increases in venous pressure and perhaps an impairment of cerebrovascular autoregulation (see Chapter 13 ). Prolonged labor and breech delivery potentially could lead to such hemodynamic effects (see Chapter 24 ). The relation of cerebral white matter injury to such clinical markers as fetal metabolic acidosis (see earlier) supports the notion that labor and delivery are important periods for careful management to prevent hypoxic-ischemic insults or the development of cerebrovascular autoregulatory dysfunction that might lead to hypoxia-ischemia subsequently. Such issues as the role of elective cesarean section or the timing of the latter in relation to duration of labor are relevant in this context (see Chapter 24 ).
Delayed Cord Clamping/Umbilical Cord Milking
These mechanisms of placental transfusion, currently under intensive study, theoretically could lead to such favorable consequences as improved hemodynamics (see Table 16.14 ; see Chapter 24 ). Whether either approach is beneficial in prevention of hypoxic-ischemic insults and cerebral white matter injury is unknown. Currently infants who require resuscitation are not candidates for these approaches (see Chapter 24 ).
Newborn Resuscitation
The importance of prompt temperature stabilization and establishment of adequate ventilation and perfusion in the newly born premature infant is paramount. Hypoxemia and hypercarbia should be avoided because these two conditions can result in a pressure-passive circulation (see Chapter 13 ). Because of a structurally immature myocardium, the VLBW infant has limited capacity to adapt to the pronounced changes in pre- and afterload occurring around the time of birth. This transient phenomenon may lead to reduced systemic and cerebral blood flow (CBF). A recent small study showed that impaired perfusion on day one correlates with an adverse outcome (IVH and PVL). Thus the findings define “ a vulnerable phase of the circulation during adaptation ” and indicate the importance of extra vigilance in management of the circulation at this time.
Concern for potential deleterious effects of hyperoxia (e.g., oxidative stress, vasoconstriction, organ injury—including retina and brain) led in the first decade of this century to a major change in practice from the use in resuscitation of 100% oxygen to much lower levels. A survey in 2015 of 25 countries found that only 4 used 100% oxygen and greater than 70% used ≤40% oxygen. In addition, the 2015 guidelines released by an International Consensus group, including the American Heart Association, recommended that resuscitation of preterm newborns less than 35 weeks’ gestation be initiated with relatively low oxygen levels, 21% to 30%. However, the largest randomized controlled trial to date recently showed that resuscitation of infants less than 28 weeks’ gestation with room air versus 100% oxygen resulted in higher hospital mortality (22% vs. 6%). Similarly, a large retrospective Canadian study showed that after a change of resuscitation guidelines from 100% to room air, severe neurological injury increased (OR 1.36, CI 1.11 to 1.66). More data are needed concerning this important issue.
Ventilation
Maintenance of adequate ventilation is a central aspect of postnatal supportive care , an imprecise term that refers to the maintenance also of temperature, perfusion, and metabolic status. The importance of these various postnatal aspects of management cannot be overemphasized; disturbances of ventilation and perfusion particularly may play an important role in determining the ultimate severity of neurological injury.
Oxygen
In the following discussion we will review the deleterious effects of overt hypoxemia and hyperoxemia. The issue of the optimal range of oxygen saturation in premature infants has been the topic of considerable research in recent years. The principal comparisons have been between groups with oxygen saturation targets of 85% to 89% versus 91% to 95%. No dramatic differences in outcomes were observed, although in the most recent study the lower oxygen saturation group had nonsignificantly higher rates of death or disability at 2 years but significantly increased risks of this combined outcome and of death alone in post hoc combined analyses. In general, the neurodevelopmental outcomes and rates of serious ROP were similar between the two groups, although necrotizing enterocolitis, a major risk factor for cerebral white matter injury (see earlier), occurred less frequently in the higher oxygen group. The most reasonable current conclusion is that “targeting an oxygen saturation of 91% to 95% is safer than targeting an oxygen saturation of 85% to 89%.”
Hypoxemia.
Avoidance of oxygen deprivation is a cornerstone of supportive therapy. Hypoxemia may lead to a disturbance of cerebrovascular autoregulation and, as a consequence, a pressure-passive circulation ( Table 16.15 ; see Chapter 13 ). Under such circumstances, the infant is vulnerable to ischemic cerebral white matter injury with only moderate decreases in arterial blood pressure (see Chapter 15 ). Indeed, this hemodynamic mechanism may be the most important by which hypoxemia leads to parenchymal injury. The propensity for white matter injury presumably relates in part to the limited vasodilatory capacity in neonatal cerebral white matter in the presence of anaerobic glycolysis, increased substrate demand and a cellular population, pre-OLs, exquisitely vulnerable to hypoxia-ischemia and resulting oxidative attack (see Chapter 15 ).
Hypoxia |
|
Hyperoxia |
|
Concerning detection and causes of hypoxemia , very diligent surveillance is critical. The use of pulse oximetry and transcutaneous oxygen monitoring has demonstrated that among infants in neonatal intensive care facilities, especially low-birth-weight infants, episodes of hypoxemia are more frequent than often thought and are readily overlooked by periodic sampling of arterial blood. Thus continuous transcutaneous oxygen or pulse oximetry monitoring in sick, low-birth-weight infants has detected some very frequent and, in some cases, previously unsuspected causes of hypoxemia ( Table 16.16 ).
Feeding procedures |
Overfeeding with abdominal distention, neck flexion, and hand-under-jaw feeding |
Crying |
Airway manipulations |
Suctioning, neck flexion, neck hyperextension, and poorly placed nasal mask or endotracheal tube |
Diagnostic procedures |
Painful procedures and abdominal examination with compression |
Seizures |
Apneic episodes |
Other |
Handling, excessive noise, active sleep, and ambient temperature out of infant’s thermoneutral zone |
Continuous transcutaneous oxygenation measurement via pulse oximetry has become standard practice, but it would be more relevant to measure cerebral oxygenation via near infrared spectroscopy (NIRS; Chapter 10 ). For example, NIRS has been used to show that hypoxemia with apnea results in cerebral deoxygenation. In a multicenter, phase II, randomized trial of 166 infants born at less than 28 weeks’ gestation, continuous NIRS monitoring was used during the first 72 hours of life with a standardized approach to maintaining cerebral oxygenation. This regimen was associated with a significant reduction of time spent with cerebral oxygenation below 55%, but serial cranial ultrasound studies and MRI at term equivalent age did not show any difference in severity of injury in monitored and control infants. However, it has been suggested that the incidence of intermittent hypoxia in extremely low-birth-weight infants progressively increases over the first 4 weeks of postnatal life, with a subsequent plateau followed by a slow decline beginning at weeks 6 to 8, raising the possibility that longer-term cerebral monitoring may be useful. This timing is interesting because some clinical, imaging, and neuropathological data suggest that the first days and weeks of life are critical, concerning the timing of cerebral white matter injury (see earlier) . Overall, while the use of continuous NIRS monitoring of cerebral oxygenation is promising, there is not yet sufficient evidence from outcome-based clinical trials to recommend its routine use.
Hyperoxia.
Although hypoxemia is serious and requires prompt reaction, overreaction also may be deleterious if hyperoxia is produced (see Table 16.15 ). The latter may lead to white matter or neuronal injury . Experimental studies also show that hyperoxia can lead to cerebral white matter injury similar to PVL (see Chapter 15 and later). Moreover, the neuropathological data reviewed in Chapter 14 suggest a role for hyperoxia in the genesis of a specific pattern of neuronal injury, pontosubicular necrosis. In addition, the possibility that hyperoxia may contribute to neuronal and white matter injury by causing a reduction in CBF must be considered. Reductions of CBF of 20% to 30% were shown with hyperoxia in newborn puppies, although the arterial oxygen tensions (PaO 2 ) of approximately 350 mm Hg used were very high. Notably, in human premature infants, CBF measured by xenon clearance 2 hours after birth was 23% lower in infants who were resuscitated with 80% oxygen versus infants resuscitated with room air. In view of the critical role of cerebral ischemia in the genesis of cerebral white matter injury, this apparent effect of hyperoxia requires further study, especially in view of the recent studies concerning oxygen levels in resuscitation (see earlier).
Finally, although the cause of ROP is now recognized to be complex, hyperoxia remains an important factor. Nevertheless, the use of lower oxygen levels in preterm infants to reduce the risk of retinopathy of maturity remains an area of active research. In a recent meta-analysis, lower oxygen saturation targets did reduce the risk of ROP, but were also associated with higher mortality. The issue of recommended oxygen saturation target range was discussed earlier.
Is the Optimal Oxygen Saturation in Premature Infants Age-Dependent?
Recent experimental studies raise the question of whether the identification of optimal oxygen tension for premature infants depends not only on the absolute value but also the postnatal age of the infant. Thus at birth the transition from intrauterine placental to postnatal pulmonary oxygenation results in a drastic increase in brain oxygenation. This abrupt increase in oxygenation leads in experimental models to a diminution in brain expression of the hypoxia-inducible factor, HIF 1α/HIF 2α genes. Among the results of the latter is an increase in Wnt signaling and a decrease in VEGF expression, unlike the normal physiological situation with lower oxygen tension in fetal brain during pregnancy. These molecular events result in a diminution in angiogenesis , particularly in periventricular vessels, which are the last to mature in developing white matter. The anatomical consequences are periventricular vascular underdevelopment and local hypoxia-ischemia with the propensity to development of focal periventricular necrosis and cyst formation , that is, typical cystic PVL. (Note that this mechanism does not involve oxidative stress which, as described in Chapter 15 , appears to be important in a neonatal rodent model of hyperoxia-induced PVL.) Later, under conditions of hypoxia, as can occur in the postnatal period because of pulmonary, cardiac, and other neonatal complications, there is upregulation of HIF 1α/HIF 2α and Wnt signaling that leads to arrest of pre-OL maturation diffusely in cerebral white matter . The result of the pre-OL maturation failure, of course, would be hypomyelination, the hallmark of the diffuse component of PVL, as observed in both clinical and experimental studies (see earlier and Chapter 14 ). Accompanying upregulation of VEGF leads to enhancement of angiogenesis and thereby a decline in propensity to periventricular cystic lesions. (The similarities of this pathophysiology to ROP are apparent, wherein the initial relative hyperoxia leads to diminished retinal angiogenesis and, as a result, retinal hypoxia-ischemia, with the latter then resulting in retinal injury and excessive angiogenesis.) The implications for management of the premature infant are that hyperoxia should be avoided, especially in the early postnatal period. Indeed, it has been postulated that “restraint in using high Fi0 2 with careful monitoring of arterial oxygen saturation by pulse oximetry might have contributed to the decline of cystic PVL observed over the last decades.” Whether a graded postnatal increase in Fi0 2 levels from early to later in the postnatal period would be appropriate management for the sick premature infant is an important question, based on the experimental data just described. More data are needed on these critical issues.
Carbon Dioxide
Because PaCO 2 may have serious metabolic and vascular effects, careful control thereof is critical (see Table 16.14 ). As with oxygen determinations, periodic sampling of arterial blood is not an optimal means to monitor PaCO 2 serially. Experience with continuous transcutaneous monitoring of PCO 2 or serial measurements of end-tidal carbon dioxide pressure indicates that events as frequent as, and often similar to, those recorded in Table 16.16 result in marked changes in PaCO 2 . However, the use of end-tidal CO 2 is somewhat problematic in premature infants for such technical issues as leakage around uncuffed endotracheal tubes and other factors. Sampling breath close to the carina by measuring distal end-tidal CO 2 is less susceptible to such factors. A recent small study showed that the latter approach improved ability to maintain infant CO 2 levels in a predetermined safe range (PCO 2 30 to 60 mm Hg) and led to a decline in incidence of IVH and PVL.
Hypercarbia.
Marked elevations of PaCO 2 are particularly dangerous in such infants because of the resulting increase in tissue PCO 2 and consequent worsening of intracellular acidosis in brain ( Table 16.17 ). Perhaps more important than the metabolic effects and worsening of tissue acidosis are the vascular effects of hypercarbia. Thus hypercarbia results in an impairment of cerebrovascular autoregulation and, as a consequence, a pressure-passive circulation (see Chapter 13 ). In one study of 43 ventilated preterm infants in the first week of life, a progressive loss of vascular autoregulation was observed with PaCO 2 values of 45 mm Hg or greater. As noted previously concerning hypoxemia, with hypercarbia the infant becomes especially vulnerable to ischemic cerebral injury with decreases in arterial blood pressure. Moreover, because of the potent vasodilatory effect of hypercarbia, CBF may increase and may cause a risk of hemorrhage in vulnerable capillary beds (e.g., germinal matrix and thereby intraventricular hemorrhage). These adverse effects with marked hypercarbia should be contrasted with the apparent beneficial effects of mild hypercarbia during hypoxia-ischemia (see later).
Hypercarbia (marked) |
|
Hypocarbia |
|